Population pharmacokinetic and pharmacodynamic analysis in allergic diseases

References

• Aarons, L., Karlsson, M., Mentré, F., Rombout, F., Steimer, J-L., van Peer, A., and invited, COST B15 Experts. (2001). Role of modelling and simulation in phase I drug development. Eur J Pharm Sci 115–122.
   PubMed Web of Science ®Google Scholar
• Aventis Pharmaceuticals. (2005). Allegra-D (fexofenadine hydrochloride, pseudoephedrine hydrocloride) 12-hour extended released tablets in PDR. Physician Desk reference (electronic version). Greenwood Village, Colorado, USA: Thomson Micromedex.
   Google Scholar
• Awni, W., Cao, G., Locke, C. (1995). Population modeling of leukotriene B4 (LTB4) inhibition by zileutron in asthmatic children. [abstract] Pharmaceut Res 12(Suppl 9):S-362).
   Google Scholar
• Dyck, J.B., Haack, D.L., Azarnoff, L., Vuorilehto, L., Shafer, S.L. (1993). Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 78:821–828.
   PubMed Web of Science ®Google Scholar
• Duan, J.Z. (2007). Applications of population pharmacokinetics in current drug labelling. J Clin Pharm Ther 32:57–79.
   PubMed Web of Science ®Google Scholar
• Duffull, S.B., Friberg, L.E., Dansirikul, C. (2007). Bayesian hierarchical modelling with Markov chain Monte Carlo methods. In: Ette, E.I., Williams, P.J. (Eds.), Pharmacometrics: The Science of Quantitative Pharmacology. Hoboken, NJ, USA, John Wiley & Sons, Inc.
   Google Scholar
• Duffull, S.B., Kirkpatrick, C.M., Green, B. (2005). Analysis of population pharmacokinetic data using NONMEM and WinBUGS. J Biopharm Stat 15:53–73.
   PubMed Web of Science ®Google Scholar
• EMEA. (2006). Guideline on reporting the results of population pharmacokinetic analyses. EMEA/CHMP/EWP/185990/2006. Released for consultation: June 21, 2007. Online at: http://www.emea.eu.int/pdfs/human/ewp/18599006en.pdf
   Google Scholar
• Evans, L., Aarons, L., Brearley, C. (2005). A pharmacokinetic/pharmacodynamic model for a platelet activating factor antagonist based on data arising from phase I studies. J Pharm Pharmacol 57:183–189.
   PubMed Web of Science ®Google Scholar
• FDA. (1999). Guidance for Industry: Population Pharmacokinetics. Silver Spring, Maryland, USA: U.S. Food and Drug Administration.
   Google Scholar
• Fitzmaurice, G., Davidian, M., Verbeke, G., Molenberghs, G. (2008). Longitudinal Data Analysis. London, UK, Chapman & Hall/CRC Press, 632 pp.
   Google Scholar
• Frossard, N., Strollin-Benedetti, M., Purohit, A., Pauli, G. (2007). Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Br J Clin Pharmacol 65:172–179.
   PubMed Web of Science ®Google Scholar
• Gobeau, N., Sargentini-Maier, M-L. (2008). Restrospective population pharmacokinetics of levocetirizine in children from 6 months to 6 years. Abstract ACAAI, November 6–11, 2008, Seattle, Washington, USA.
   Google Scholar
• Gustafsson, L.L., Ebling, W.F., Osaki, E., Harapat, S., Stanski, D.R., Shafer, S.L. (1992). Plasma concentration clamping in the rat using a computer-controlled infusion pump. Pharm Res 9:800–807.
   PubMed Web of Science ®Google Scholar
• Hayashi, N., Tsukamoto, Y., Sallas, W., Lowe, P. (2006). A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab. Br J Clin Pharmacol 63:548–561.
   PubMed Web of Science ®Google Scholar
• Hochhaus, G., Gonzalez, M., Dockhorn, R., Shilstone, J., Karafilidis, J. (2002). A new solution-based intranasal triamcinolone acetonide formulation in patients with perennial alergic rhinitis: how does the pharmacokinetic/pharmacodynamic profile for cortisol suppression compare with an aqueaous suspension-based formulation? J Clin Pharmacol 42:662–669.
   PubMed Web of Science ®Google Scholar
• Hussein, Z., Pitsiu, M., Majid, O., Aarons, L., de Longueville, M., Stockis, A., on behalf of the ETAC Study Group. (2005). Retrospective population pharmacokinetic analysis of levocetirizine in atopic children receiving cetirizine. Br J Clin Pharmacol 59:28–37.
   PubMed Web of Science ®Google Scholar
• Jacqmin, P., Stockis, A. (2003). Population pharmacokinetic and pharmacodynamic analysis after oral administration of two different formulations of efletirizine in healthy volunteers. UCB data on file, UCB Pharma SA, Braine l'Alleud, Belgium.
   Google Scholar
• Levy, G., Hollister, L.E. (1964). Inter- and intrasubject variations in drug absorption kinetics. J Pharm Sci 53:1446–1452.
   PubMed Web of Science ®Google Scholar
• Lunn, D.J., Best, N., Thomas, A., Wakefield, J., Spiegelhalter, D. (2002). Bayesian analysis of population PK/PD models: general concepts and software. J Pharmacokinet Pharmacodyn 29:271–307.
   PubMed Web of Science ®Google Scholar
• Marier, J.F., Ducharme, M.P. (2001). A population pharmacokinetic/pharmacodynamic (PK-PD) model to determine the bioequivalence of albuterol using rate and extent of absorption derived from FEV1 measurements. Clin Pharm Ther 69:P59.
   Web of Science ®Google Scholar
• Matis, J.H., Tolley, H.D. (1980). On the stochastic modeling of tracer kinetics. Fed Proc 39:104–109.
   PubMedGoogle Scholar
• Mentré, F., Dubruc, C., Thenot, J-P. (2001). Population pharmacokinetic analysis and optimization of the experimental design for mizolastine solution in children. J Pharmacokinet Pharmacodyn 28:299–319.
   PubMed Web of Science ®Google Scholar
• Parker, T., Daley-Yates, P., Wood, S. (1997). A comparative population pharmacokinetic analysis for methylprednisolone following multiple dosing of two prodrugs in patients with acute asthma. Br J Clin Pharmacol 43:589–592.
   PubMed Web of Science ®Google Scholar
• Piotrovsky, V.K. (2000). Population pharmacodynamic and pharmacokinetic modeling via mixed effects. Curr Opin Drug Discov Dev 3:314–330.
   PubMedGoogle Scholar
• Pitsiu, M., Hussein, Z., Majid, O., Aarons, L., de Longueville, M., Stockis, A. (2004). Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years. Br J Clin Pharmacol 57:402–411.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan, R., Migoya, E., Knorr, B. (2005). A population pharmacokinetic model for Montelukast disposition in adults and children. Pharm Res 22:532–540.
   PubMed Web of Science ®Google Scholar
• Shafer, S.L., Varvel, J.R., Aziz, N., Scott, J.C. (1990). Pharmacokinetics of fentanyl administered by computer-controlled infusion pump. Anesthesiology 73:1091–1102.
   PubMed Web of Science ®Google Scholar
• Sheiner, L.B., Beal, S.L. (1980). Evaluation of methods for estimating population pharmacokinetics parameters. I. Michaelis-Menten model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 8:553–571.
   PubMedGoogle Scholar
• Sheiner, B.L., Beal, S.L. (1981). Evaluation of methods for estimating population pharmacokinetic parameters. II. Biexponential model and experimental pharmacokinetic data. J Pharmacokinet Biopharm 9:635–651.
   PubMedGoogle Scholar
• Sheiner, B.L., Beal, S.L. (1983). Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: routine clinical pharmacokinetic data. J Pharmacokinet Biopharm 11:303–319.
   PubMedGoogle Scholar
• Sheiner, L.B., Ludden, T.M. (1992). Population pharmacokinetics dynamics. Annu Rev Pharmacol Toxicol 32:185–209.
   PubMed Web of Science ®Google Scholar
• Sheiner, L.B., Rosenberg, B., Marathe, V.V. (1977). Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. J Pharmacokinet Biopharm 5:445–479.
   PubMedGoogle Scholar
• Sheiner, L.B., Rosenberg, B., Melmon, K.L. (1972). Modelling of individual pharmacokinetics for computer-aided drug dosage. Comput Biomed Res 5:411–459.
   PubMedGoogle Scholar
• Simons, F.E.R., on behalf of the ETAC Study group. (2005). Population pharmacokinetics of levocetirizine in very young children: the pediatricians’ perspective. Pediatr Allergy Immunol 16:97–103.
   PubMed Web of Science ®Google Scholar
• Stickland, M.D., Kirkpatrick, C.M., Begg, E.J., Duffull, S.B., Oddie, S.J., Darlow, B.A. (2001). An extended interval dosing method for gentamicin in neonates. J Antimicrob Chemother 48:887–893.
   PubMed Web of Science ®Google Scholar